Invitation: On August 15-16, 2024, Haib←γγu Pharmaceutical invites≤σ≈ you to gather in Su׶zhou for the 6th CMC-China Expo.

Beijing Haibu Pharmac≤ eutical Technology Coελ φ., Ltd. (referred to↔∑≥≈ as "Haibu Pharmaceut$≠ical") was established in 2005 ∏ ‍and is a high-tech enterprise with "ch✘∞±emical drug research and devel☆₽opment" as its core capab÷₩∞πility. It has a research and developmen¥↕εt center in Beijing, a pilot verif←★↔ication center for raw materials and αλ✘formulations, and a GMP indus€♠®trial production base, mainly λ‌♥ engaged in CRO services for raw mate‌φrials and formulatioγ≤≈ns, MAH joint licensin★₽g, related applications for rawΩ♥✘ materials, and commercial sup£™≤πply of pharmaceutical i÷×ntermediates.It has rich experience∞₹ in the research and production tran®‌'↑sfer, registration appli ‌λ cation, etc., of various dosage¥≤←✘ forms such as chemical raw€→ materials, oral solids, liquid pr≈↓✘•eparations, sterile injec₩✘tions, and external preparations. →δ≠The R&D products cover mult ‌§•iple therapeutic areas including ant←∏ ®i-tumor, anti-depression, anti-epileps Ω‌"y, anti-anxiety, cardio£πvascular and cerebrovascular"∞&★ diseases, digestive system disorders'‌←, respiratory system♦® issues, etc.

Haibu Pharmaceutical ha★&✘s been awarded the ti"¥×tle of "Top 20 Chinese ₽÷Pharmaceutical R&D Compa™ε≈nies" for several consecutive←¶ years and has been recognized as a "S™≈☆≤pecialized and Innovative" enterprise γ€✘ in Beijing, a "National High-tech¥☆ Enterprise", a "Beijing S& cience and Technology Research Ω"→✔Development Institution", and a "Beiji‍≠→γng Yizhuang Enterprise Innovati♥¶on Center", among others.